PAH in Practice: A Case-based Online Learning Program for Better Patient Care is a free, accredited course designed for healthcare professionals who want to enhance their clinical confidence and decision-making when managing suspected or confirmed Pulmonary Arterial Hypertension (PAH). Through real patient cases and concise expert-led lessons, this program helps you detect PAH earlier, make timely referrals, and personalize treatment strategies to improve outcomes.

This activity is an Accredited Self-Assessment Program (Section 3) under the Maintenance of Certification (MOC) Program of the Royal College of Physicians and Surgeons of Canada, approved by the Canadian Thoracic Society. 

Participants may claim up to 2.0 hours of credit. 

Who Should Take This Course

This program is designed for:

  • Respirologists and internists

  • General practitioners and trainees (residents, fellows)

  • Nurses and allied healthcare professionals working in pulmonary hypertension or cardiopulmonary care settings

What You’ll Learn

After completing this course, you will be able to:

  • Explore the clinical presentation of a patient with PAH including a focus on high risk groups and features to aid in early diagnosis.

  • Explain the key diagnostic steps and referral pathways necessary to direct patients to specialized PAH centers.

  • Identify and distinguish PAH from other forms of pulmonary hypertension and cardiopulmonary diseases utilizing clinical tools.

  • Understand treatment and prognosis using validated measures.

Enroll Now, it's free

Improve early diagnosis and optimize treatment of PAH with this free, accredited case-based learning program.

What to Expect

  • Self-paced and online (approx. 120 minutes total)

  • Interactive case-based format grounded in real clinical scenarios

  • Accredited Section 3 Self-Assessment Activity as defined by the Royal College Maintenance of Certification Program (MOC)

  • Certificate of completion issued automatically

  • Resume anytime, your progress is saved automatically

Course curriculum

  • 1

    Introduction

    • Course Introduction

  • 2

    Module 1: Pulmonary Arterial Hypertension (PAH)

    • Introduction to PAH

    • Quiz 1.A

    • Unexplained Dyspnea

    • Quiz 1.B

    • Referral & Further Investigations

    • Quiz 1.C

    • Module Summary

  • 3

    Module 2:​ Comorbidities and complex phenotypes​

    • Spectrum of Pulmonary Hypertension​

    • Quiz 2.A

    • Quiz 2.B

    • Further investigations & referral​

    • Quiz 2.C

    • When to suspect PAH in the presence of Comorbidities​

    • Quiz 2.D

    • Module summary​

  • 4

    Module 3: Treatment and Follow-up​

    • Therapeutic approaches​

    • Quiz 3.A​

    • Risk Assessment, Treatment initiation & Follow-up​

    • Quiz 3.B

    • Module Summary​

  • 5

    Understanding PAH - Patient Testimonial

    • Understanding PAH Through the Patient Lens

  • 6

    Further Reading & Key References

    • Further Reading & Key References

  • 7

    Evaluation

    • Evaluation PAH in Practice: A Case-based Online Learning Program for Better Patient Care Self-Assessment Activity

Scientific Planning Committee

Chair Dr. Steeve Provencher

Respirologist and Professor, Université de Laval

Dr. Provencher is internationally recognized for his clinical and research work in pulmonary hypertension and right heart failure, with over 100 peer-reviewed publications.

Dr. Kristina Kemp

Respirologist, The Moncton Hospital

Dr. Kemp brings frontline expertise in managing PAH patients in a regional setting and is an active medical educator and contributor to national clinical practice guidelines.

Dr. Rhea Varughese

Respirologist and Assistant Professor, University of Alberta

Dr. Varughese focuses on complex PH phenotypes and referral pathways. She is widely published and collaborates on national and international PH initiatives.

This program is co-developed by the Canadian Thoracic Society, Respiplus and Merck and is planned to achieve scientific integrity, objectivity and balance.

The course is available until September 30th 2026 and is offered in English only.